AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2005
Mar 3, 2005
35134_dirs_2005-03-03_18340d03-0034-4764-8509-035acd6742ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (coff)
CIK: 0000025743
Period of Report: 2005-02-16
Reporting Person: JENSEN GERALD L (Director, President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-02-11 | Croff Enterprises Inc Common Stock | P | 500 | $1.59 | Acquired | 247988 | Direct |
| 2005-02-22 | Croff Enterprises Inc Common stock | P | 500 | $1.59 | Acquired | 247988 | Direct |
Footnotes
F1: Includes 132,130 shares of Common held by Jensen Development Company which is wholly owned by Gerald L. Jensen.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16